Login

Florian Holzapfel on the Future of Medical Cannabis in Europe | Florian Holzapfel, CEO, Cantourage Group Se. 00:10:00

Share On Facebook Share On Twitter

Florian Holzapfel, CEO of Cantourage, explores the burgeoning opportunities in the European medical cannabis market. He emphasizes how the potential legalization of recreational marijuana could exponentially increase market growth, projecting a tenfold expansion. Holzapfel shares his vision for Cantourage's role in this evolving landscape and the company's commitment to delivering high-quality cannabis products.

Recent Videos

00:10:00
Thomas Olin Highlights Kancera’s Latest Advances and Strategic Focus | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Pablo Pereiro Discusses Squirrel Media’s 63% Profit Growth and 14.7% Stock Surge | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Steve Oliver of musicMagpie Discusses Circular Economy and Company's Growth Strategy | Steve Oliver , CEO , musicMagpie PLC.
00:10:00
Revolutionizing Healing with Naturally Derived Psychedelics | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
SMC Global Securities Launches New Office at Bahu Plaza, Jammu, to Promote Share Market Investments | Ajay Garg , CEO , SMC Global Securities Ltd.
00:10:00
Exploring Demoralization Syndrome Treatment with Filament Health’s Psilocybin Trials | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
BioInvent CEO Explores Portfolio Strategy and Upcoming Breakthroughs | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Piotr Figarski Discusses Image Power's 2022 Results and Future Trends | Piotr Figarski, Vice President , Image Power SA.
00:10:00
Pablo Pereiro and María Bonaria Fois Discuss Squirrel Media's Strategic Acquisition of Mondo TV Studios | Pablo Pereiro , CEO , Squirrel Media SA.
00:10:00
Lexington Gold Set to List on London AIM Exchange After Reverse Takeover | Dr. Bernard Olivier, CEO , Lexington Gold Ltd.
00:10:00
Thomas Olin, CEO of Kancera AB, Discusses Strategic Advances in Biopharma Innovation | Dr. Thomas Olin, CEO , Kancera AB.
00:10:00
Leading the Charge in the Psychedelic Movement with Filament Health | Benjamin Lightburn, CEO , Filament Health Corp.
00:10:00
Pini Mandel on the Power of Dynamic Pricing to Boost Retail KPIs and Customer Satisfaction | Pini Mandel , CEO , Quicklizard Ltd.
00:10:00
Jean Michel Ng Tseung, New CEO of MCB Group, Shares Vision for a Sustainable Future | Jean Michel Ng Tseung , CEO , MCB Group Ltd.
00:10:00
Viktor Garmiani Unveils Candles Scandinavia’s Q4 Report Highlights | Viktor Garmiani, CEO , Candles Scandinavia AB.
00:10:00
Squirrel Media's Record-Breaking Year: CEO Pablo Pereiro Discusses Key Strategies and Global Expansion | Pablo Pereiro , CEO , Squirrel Media SA.

Suggestions

00:10:00
Debunking 3 Common Myths About Social Security | Brian A. Remson - Advanced Planning Team at Credent Wealth Management
00:10:00
Revolutionizing Healthcare: From Genomes to Therapeutic Modalities | Jean M. Hynes, CEO , Wellington Management Company.
00:10:00
Lithium Universe Limited CEO Alex Hanly discusses downstream processing and corporate structure in an interview with ABN Newswire.| Alex Hanly CEO Of Lithium Universe Limited
00:10:00
Bane Hunter. Chief Executive Officer & Executive Director,of GetSwift Ltd.
00:10:00
From Cambridge Economics to Leading Lloyd's Banking Group | Charlie Nunn, CEO, Lloyds Banking Group.
00:10:00
Exclusive Interview: Hesai Talks AT128 Integration with Human Horizons CTO for HiPhi Z Luxury EV | Dr. Yifan "David" Li - Co-Founder & CEO of Hesai Group
00:10:00
founders need to know about responsible|Nikhil Sachdev,Managing Director,Insight Partners
00:10:00
Breaking Chains: Finding Success and Happiness
00:10:00
Westhaven Gold Announces Maiden Resource for Shovelnose Gold Property | GARETH THOMAS - President, CEO and Director of Westhaven Gold Corp.
00:10:00
Important RMD Deadline: End-of-Year Reminder
00:10:00
José Feliciano Reflects on Making a Difference and Inspiring Change |José E. Feliciano, Co-Founder, Clearlake Capital Group.
00:00:00
Developing autologous stem cell therapies for debilitating neurodegenerative diseases - Lebovits, CEO, Brainstorm Cell Therapeutics Inc

© 2017 - Townhall + Tv